ArticleCancer discovery2022

Sequential Single-Cell Transcriptional and Protein Marker Profiling Reveals TIGIT as a Marker of CD19 CAR-T Cell Dysfunction in Patients with Non-Hodgkin Lymphoma.

Zachary Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.